2-208121913-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006891.4(CRYGD):​c.285A>G​(p.Arg95Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.894 in 1,614,034 control chromosomes in the GnomAD database, including 649,097 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.87 ( 58414 hom., cov: 32)
Exomes 𝑓: 0.90 ( 590683 hom. )

Consequence

CRYGD
NM_006891.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0270

Publications

27 publications found
Variant links:
Genes affected
CRYGD (HGNC:2411): (crystallin gamma D) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. Four gamma-crystallin genes (gamma-A through gamma-D) and three pseudogenes (gamma-E, gamma-F, gamma-G) are tandemly organized in a genomic segment as a gene cluster. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008]
CRYGD Gene-Disease associations (from GenCC):
  • cataract 4 multiple types
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • cataract - microcornea syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cerulean cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • coralliform cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset lamellar cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pulverulent cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 2-208121913-T-C is Benign according to our data. Variant chr2-208121913-T-C is described in ClinVar as Benign. ClinVar VariationId is 260061.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.027 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.916 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006891.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CRYGD
NM_006891.4
MANE Select
c.285A>Gp.Arg95Arg
synonymous
Exon 3 of 3NP_008822.2
LOC100507443
NR_038437.1
n.97+2688T>C
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CRYGD
ENST00000264376.5
TSL:1 MANE Select
c.285A>Gp.Arg95Arg
synonymous
Exon 3 of 3ENSP00000264376.4P07320
ENSG00000295187
ENST00000728538.1
n.100+2688T>C
intron
N/A
ENSG00000295187
ENST00000728539.1
n.117+2688T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.873
AC:
132692
AN:
152064
Hom.:
58371
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.847
Gnomad AMI
AF:
0.971
Gnomad AMR
AF:
0.813
Gnomad ASJ
AF:
0.855
Gnomad EAS
AF:
0.593
Gnomad SAS
AF:
0.774
Gnomad FIN
AF:
0.924
Gnomad MID
AF:
0.772
Gnomad NFE
AF:
0.922
Gnomad OTH
AF:
0.862
GnomAD2 exomes
AF:
0.847
AC:
212766
AN:
251086
AF XY:
0.851
show subpopulations
Gnomad AFR exome
AF:
0.843
Gnomad AMR exome
AF:
0.760
Gnomad ASJ exome
AF:
0.857
Gnomad EAS exome
AF:
0.577
Gnomad FIN exome
AF:
0.922
Gnomad NFE exome
AF:
0.918
Gnomad OTH exome
AF:
0.873
GnomAD4 exome
AF:
0.896
AC:
1309645
AN:
1461852
Hom.:
590683
Cov.:
74
AF XY:
0.894
AC XY:
649914
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.841
AC:
28140
AN:
33480
American (AMR)
AF:
0.767
AC:
34321
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.858
AC:
22423
AN:
26136
East Asian (EAS)
AF:
0.557
AC:
22095
AN:
39700
South Asian (SAS)
AF:
0.797
AC:
68730
AN:
86254
European-Finnish (FIN)
AF:
0.923
AC:
49266
AN:
53404
Middle Eastern (MID)
AF:
0.829
AC:
4781
AN:
5768
European-Non Finnish (NFE)
AF:
0.924
AC:
1027157
AN:
1111990
Other (OTH)
AF:
0.873
AC:
52732
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
8015
16029
24044
32058
40073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21438
42876
64314
85752
107190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.873
AC:
132794
AN:
152182
Hom.:
58414
Cov.:
32
AF XY:
0.869
AC XY:
64663
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.847
AC:
35146
AN:
41516
American (AMR)
AF:
0.813
AC:
12427
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.855
AC:
2966
AN:
3468
East Asian (EAS)
AF:
0.593
AC:
3063
AN:
5164
South Asian (SAS)
AF:
0.775
AC:
3732
AN:
4814
European-Finnish (FIN)
AF:
0.924
AC:
9789
AN:
10590
Middle Eastern (MID)
AF:
0.776
AC:
228
AN:
294
European-Non Finnish (NFE)
AF:
0.922
AC:
62743
AN:
68020
Other (OTH)
AF:
0.859
AC:
1814
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
830
1660
2491
3321
4151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
894
1788
2682
3576
4470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.900
Hom.:
252263
Bravo
AF:
0.862
Asia WGS
AF:
0.653
AC:
2271
AN:
3478
EpiCase
AF:
0.916
EpiControl
AF:
0.915

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Cataract 4 multiple types (2)
-
-
2
not provided (2)
-
-
1
Aculeiform cataract (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
7.8
DANN
Benign
0.70
PhyloP100
-0.027
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2305430; hg19: chr2-208986637; COSMIC: COSV108051169; API